| Code | CSB-MP872550HU |
| Abbreviation | Recombinant Human GP6 protein, partial (Active) |
| MSDS | |
| Size | $256 |
| Order now | |
| Image |
|
| Have Questions? | Leave a Message or Start an on-line Chat |
Platelet glycoprotein VI mediates collagen-induced platelet activation and thrombus formation, making it a critical target for understanding thrombotic disorders and developing antiplatelet therapeutics. This mammalian-expressed construct spanning residues 21–267 captures the extracellular ligand-binding domain and demonstrates quantified antibody-binding activity with an EC50 of 3.598–4.105 ng/mL in functional ELISA, providing a validated basis for therapeutic antibody epitope mapping, competitive inhibition screening, and blocking antibody validation studies. The native post-translational modifications conferred by mammalian expression support conformational integrity required for ligand-binding assays, surface plasmon resonance affinity characterization, and biolayer interferometry experiments that probe receptor-ligand interactions. Purity exceeding 95% by SDS-PAGE and endotoxin levels below 1.0 EU/μg align with standards expected in drug discovery workflows targeting GP6-mediated platelet signaling pathways.
There are currently no reviews for this product.